CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS

C. TERRAGNA;D. REMONDINI;G. MARTINELLI;P. TOSI;E. ZAMAGNI;P. TACCHETTI;G. PERRONE;A. BRIOLI;M. CECCOLINI;N. TESTONI;G. MARZOCCHI;G. CASTELLANI;S. DURANTE;DI RAIMONDO, FRANCESCO;F. PATRIARCA;L. CATALANO;L. MASINI;A. LEDDA;E. ANGELUCCI;P. GALIENI;A. GOZZETTI;M. BACCARANI;M. CAVO

2010-01-01